• March 27 - 30, 2017, San Francisco

    2017 Joint Summits

Call for Participation for 2017 Summit on Translational Bioinformatics

Submission Deadline: September 22, 2016, 11:59 p.m. EDT

AMIA is pleased to invite submissions for the 2017 Summit on Translational Bioinformatics (TBI), to be held March 27 – March 30, 2017, at the Parc 55 Hotel in San Francisco, California. The Summit will be part of the Joint Summits on Translational Science and will be held in conjunction with the Summit on Clinical Research Informatics (CRI) at the same venue. TBI Summit-only programming will be on Monday, March 27. CRI Summit-only programming will be on March 30. There will be an invigorated effort to integrate the CRI and TBI aspects for the Joint Summits this year, and a special call for submissions that have relevance to both CRI and TBI communities. TBI and CRI will have joint programming on Tuesday, March 28 and Wednesday, March 29.

Through tutorials, lectures, panels, and posters, the 2017 TBI Summit will showcase the latest advances in bioinformatics methodology, discovery, and, increasingly, in actual clinical care through applications of personalized medicine. 

With an emphasis on cutting edge and late breaking developments, we anticipate that the TBI Summit will continue to be the premier venue for showcasing the latest bioinformatics research at the dynamic interface of biomedical research and patient care. We look forward to your submissions, which we hope will provide a rich program of cutting-edge, innovative approaches in the field of Translational Bioinformatics.

Submission Deadline: September 22, 2016, 11:59 p.m. EDT

IMPORTANT! Submissions that do not meet the following requirements may be rejected without review: READ the submission guidelines and follow the sample format.

All submissions must be made through the submission site.

Submission Categories

  • Papers
  • Student Papers
  • Podium Abstract Presentations
  • Posters
  • Panels
  • Tutorials

Learning Objectives

After participating in the 2017 AMIA Summit on Translational Bioinformatics, learners should be better able to:

  • Describe state-of-the-art informatics approaches, theories, and methods relevant to clinical and translational science
  • Apply the latest findings from research and development of informatics applications that support clinical and translational biomedical research
  • Consider possible frameworks for deploying and assessing clinical research informatics initiatives
  • Interact with professionals engaged in clinical and translational science including clinical and translational investigators, data scientists, computational biologists, genomics researchers, statistical geneticists, clinical- and bio- informaticians, public health informaticians, and those involved with clinical and research IT policy and regulatory issues
  • Explore research-related initiatives emerging from national and international clinical and translational research informatics initiatives

Target Audience

  • Faculty, staff scientists, educators, students, post-docs and investigators with an interest in applied biomedical informatics that advances clinical and translational science
  • Biomedical and health informatics researchers in academia and industry
  • Data scientists working with biomedical datasets
  • Bioinformaticians, statistical geneticists, molecular biologists, and physician-scientists with interest in omic data
  • Clinical and Translational Science Award (CTSA) researchers
  • Patient Centered Outcomes Research Institute (PCORI) researchers
  • Computer scientists and system developers
  • Computational biologists with interests in human disease, drug discovery, drug repurposing, and drug response
  • Genome science ethicists, lawyers, and policy experts
  • Government officials and policy makers
  • Health information and knowledge management professionals
  • HIT industry professionals and consultants
  • Industry representatives related to bioinformatics and genomics
  • Physicians, nurses, dentists, pharmacists, and other clinicians
  • Public health informaticians/practitioners, patient advocates, consumer advocates, and disease management specialists
  • Standards developers, with particular emphasis on EHR data repurposing or integration of omic data into EHRs